• 1
    Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998;351:12251232.
  • 2
    Braunstahl GJ, Kleinjan A, Overbeek SE, Prins JB, Hoogsteden HC, Fokkens WJ. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med 2000;161:20512057.
  • 3
    Hellings PW, Hessel EM, Van den Oord J, Kasran A, Van Hecke P, Ceuppens JL. Eosinophilic rhinitis accompanies the development of lower airway inflammation and hyperreactivity in sensitized mice exposed to aerosolized allergen. Clin Exp All 2001;31:782790.
  • 4
    Togias A. Systemic effects of local allergic disease. J Allergy Clin Immunol 2004;113:S8S14.
  • 5
    Hellings PW, Ceuppens JL. Mouse models of global airway allergy: what have we learned and what should we do next? Allergy 2004;59:914919.
  • 6
    Sazonov Kocevar V, Thomas J 3rd, Jonsson L, Valovirta E, Kristensen F, Yin DD et al. Association between allergic rhinitis and hospital resource use among asthmatic children in Norway. Allergy 2005;60:338342.
  • 7
    Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108:S147S334.
  • 8
    Raherison C, Montaudon M, Stoll D, Wallaert B, Darras J, Chanez P et al. How should nasal symptoms be investigated in asthma? A comparison of radiologic and endoscopic findings. Allergy 2004;59:821826.
  • 9
    Bousquet J, Lund VJ, Van Cauwenberge P, Bremard-Oury C, Mounedji N, Stevens MT et al. Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial. Allergy 2003;58:733741.
  • 10
    Dahl R, Nielsen LP, Kips J, Foresi A, Cauwenberge P, Tudoric N et al. Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma. Allergy 2005;60:875881.
  • 11
    Custovic A, Wijk RG. The effectiveness of measures to change the indoor environment in the treatment of allergic rhinitis and asthma: ARIA update (in collaboration with GA(2)LEN). Allergy 2005;60:11121115.
  • 12
    Corren J, Manning BE, Thompson SF, Hennessy S, Strom BL. Rhinitis therapy and the prevention of hospital care for asthma: a case–control study. J Allergy Clin Immunol 2004;113:415419.
  • 13
    Vignola AM, Humbert M, Bousquet J, Boulet LP, Hedgecock S, Blogg M et al. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR. Allergy 2004;59:709717.
  • 14
    Haye R, Aanesen JP, Burtin B, Donnelly F, Duby C. The effect of cetirizine on symptoms and signs of nasal polyposis. J Laryngol Otol 1998;112:10421046.
  • 15
    Braunstahl GJ, Overbeek SE, Kleinjan A, Prins JB, Hoogsteden HC, Fokkens WJ. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 2001;107:469476.
  • 16
    Wark PA, Johnston SL, Bucchieri F, Powell R, Puddicombe S, Laza-Stanca V et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005;201:937947.
  • 17
    Xepapadaki P, Papadopoulos NG, Bossios A, Manoussakis E, Manousakas T, Saxoni-Papageorgiou P. Duration of postviral airway hyperresponsiveness in children with asthma: effect of atopy. J Allergy Clin Immunol 2005;116:299304.
  • 18
    Alho OP. Nasal airflow, mucociliary clearance, and sinus functioning during viral colds: effects of allergic rhinitis and susceptibility to recurrent sinusitis. Am J Rhinol 2004;18:349355.
  • 19
    Alho OP, Karttunen TJ, Karttunen R, Tuokko H, Koskela M, Suramo I et al. Subjects with allergic rhinitis show signs of more severely impaired paranasal sinus functioning during viral colds than nonallergic subjects. Allergy 2003;58:767771.
  • 20
    Laoukili J, Perret E, Willems T, Minty A, Parthoens E, Houcine O et al. IL-13 alters mucociliary differentiation and ciliary beating of human respiratory epithelial cells. J Clin Invest 2001;108:18171824.
  • 21
    Avila PC, Abisheganaden JA, Wong H, Liu J, Yagi S, Schnurr D et al. Effects of allergic inflammation of the nasal mucosa on the severity of rhinovirus 16 cold. J Allergy Clin Immunol 2000;105:923932.
  • 22
    Rosenberg HF, Domachowske JB. Eosinophils, ribonucleases and host defense: solving the puzzle. Immunol Res 1999;20:261274.
  • 23
    Hellings PW, Kasran A, Liu Z, Vandekerckhove P, Wuyts A, Overbergh L et al. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am J Respir Cell Mol Biol 2003;28:4250.
  • 24
    Sanders SP, Siekierski ES, Porter JD, Richards SM, Proud D. Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line. J Virol 1998;72:934942.
  • 25
    Skoner DP, Doyle WJ, Seroky J, Van Deusen MA, Fireman P. Lower airway responses to rhinovirus 39 in healthy allergic and nonallergic subjects. Eur Respir J 1996;9:14021406.
  • 26
    Alho OP, Karttunen R, Karttunen TJ. Nasal mucosa in natural colds: effects of allergic rhinitis and susceptibility to recurrent sinusitis. Clin Exp Immunol 2004;137:366372.
  • 27
    Fraenkel DJ, Bardin PG, Sanderson G, Lampe F, Johnston SL, Holgate ST. Immunohistochemical analysis of nasal biopsies during rhinovirus experimental colds. Am J Respir Crit Care Med 1994;150:11301136.
  • 28
    Friedlander SL, Busse WW. The role of rhinovirus in asthma exacerbations. J Allergy Clin Immunol 2005;116:267273.
  • 29
    Papadopoulos NG, Bates PJ, Bardin PG, Papi A, Leir SH, Fraenkel DJ et al. Rhinoviruses infect the lower airways. J Infect Dis 2000;181:18751884.
  • 30
    Dahl ME, Dabbagh K, Liggitt D, Kim S, Lewis DB. Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat Immunol 2004;5:337343.
  • 31
    Dakhama A, Park JW, Taube C, Chayama K, Balhorn A, Joetham A et al. The role of virus-specific immunoglobulin E in airway hyperresponsiveness. Am J Respir Crit Care Med 2004;170:952959.
  • 32
    Fokkens W, Lund V, Bachert C, Clement P, Helllings P, Holmstrom M et al. EAACI Position Paper on Rhinosinusitis and Nasal Polyps: Executive Summary. Allergy 2005;60:583601.
  • 33
    Savolainen S. Allergy in patients with acute maxillary sinusitis. Allergy 1989;44:116122.
  • 34
    Karlsson G, Holmberg K. Does allergic rhinitis predispose to sinusitis? Acta Otolaryngol Suppl 1994;515:2628; discussion 29.
  • 35
    Benninger MS. Rhinitis, sinusitis and their relationships to allergies. Am J Rhinol 1992;6:3743.
  • 36
    Emanuel IA, Shah SB. Chronic rhinosinusitis: allergy and sinus computed tomography relationships. Otolaryngol Head Neck Surg 2000;123:687691.
  • 37
    Collins JG. Prevalence of selected chronic conditions: United States, 1990–1992. Vital Health Stat 1997;10:189.
  • 38
    Greisner WA 3rd, Settipane RJ, Settipane GA. Co-existence of asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Asthma Proc 1998;19:185188.
  • 39
    Chen Y, Dales R, Lin M. The epidemiology of chronic rhinosinusitis in Canadians. Laryngoscope 2003;113:11991205.
  • 40
    Gordts F, Clement PA, Buisseret T. Prevalence of sinusitis signs in a non-ENT population. ORL J Otorhinolaryngol Relat Spec 1996;58:315319.
  • 41
    Iwens P, Clement PA. Sinusitis in allergic patients. Rhinology 1994;32:6567.
  • 42
    Naclerio RM, DeTineo ML, Baroody FM. Ragweed allergic rhinitis and the paranasal sinuses. A computed tomographic study. Arch Otolaryngol Head Neck Surg 1997;123:193196.
  • 43
    Pelikan Z, Pelikan-Filipek M. Role of nasal allergy in chronic maxillary sinusitis – diagnostic value of nasal challenge with allergen. J Allergy Clin Immunol 1990;86:484491.
  • 44
    Georgitis JW, Matthews BL, Stone B. Chronic sinusitis: characterization of cellular influx and inflammatory mediators in sinus lavage fluid. Int Arch Allergy Immunol 1995;106:416421.
  • 45
    Adkins TN, Goodgold HM, Hendershott L, Slavin RG. Does inhaled pollen enter the sinus cavities? Ann Allergy Asthma Immunol 1998;81:181184.
  • 46
    Blair C, Nelson M, Thompson K, Boonlayangoor S, Haney L, Gabr U et al. Allergic inflammation enhances bacterial sinusitis in mice. J Allergy Clin Immunol 2001;108:424429.
  • 47
    Braunstahl GJ, Hellings PW. Allergic rhinitis and asthma: the link further unraveled. Curr Opin Pulm Med 2003;9:4651.
  • 48
    Denburg JA, Sehmi R, Saito H, Pil-Seob J, Inman MD, O'Byrne PM. Systemic aspects of allergic disease: bone marrow responses. J Allergy Clin Immunol 2000;106:S242246.
  • 49
    Piette V, Bousquet C, Kvedariene V, Dhivert-Donnadieu H, Crampette L, Senac JP et al. Sinus CT scans and mediator release in nasal secretions after nasal challenge with cypress pollens. Allergy 2004;59:863868.
  • 50
    Braun JJ, Alabert JP, Michel FB, Quiniou M, Rat C, Cougnard J et al. Adjunct effect of loratadine in the treatment of acute sinusitis in patients with allergic rhinitis. Allergy 1997;52:650655.
  • 51
    Lane AP, Pine HS, Pillsbury HC 3rd. Allergy testing and immunotherapy in an academic otolaryngology practice: a 20-year review. Otolaryngol Head Neck Surg 2001;124:915.
  • 52
    Carayol N, Crampette L, Mainprice B, Ben-Soussen P, Verrecchia M, Bousquet J et al. Inhibition of mediator and cytokine release from dispersed nasal polyp cells by mizolastine. Allergy 2002;57:10671070.
  • 53
    Bachert C, Gevaert P, Holtappels G, Cuvelier C, Van Cauwenberge P. Nasal polyposis: from cytokines to growth. Am J Rhinol 2000;14:279290.
  • 54
    Blumstein GI, Tuft L. Allergy treatment in recurrent nasal polyposis: its importance and value. Am J Med Sci 1957;234:269280.
  • 55
    Settipane GA, Chafee FH. Nasal polyps in asthma and rhinitis. A review of 6037 patients. J Allergy Clin Immunol 1977;59:1721.
  • 56
    Bunnag C, Pacharee P, Vipulakom P, Siriyananda C. A study of allergic factor in nasal polyp patients. Ann Allergy 1983;50:126132.
  • 57
    Caplin I, Haynes JT, Spahn J. Are nasal polyps an allergic phenomenon? Ann Allergy 1971;29:631634.
  • 58
    Johansson L, Akerlund A, Holmberg K, Melen I, Bende M. Prevalence of nasal polyps in adults: the Skovde population-based study. Ann Otol Rhinol Laryngol 2003;112:625629.
  • 59
    Jorissen MB, De Boeck K, Cuppens H. Genotype-phenotype correlations for the paranasal sinuses in cystic fibrosis. Am J Respir Crit Care Med 1999;159:14121416.
  • 60
    Hamilos DL, Leung DY, Wood R, Cunningham L, Bean DK, Yasruel Z et al. Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol 1995;96:537544.
  • 61
    Bachert C, Wagenmann M, Rudack C, Hopken K, Hillebrandt M, Wang D et al. The role of cytokines in infectious sinusitis and nasal polyposis. Allergy 1998;53:213.
  • 62
    Bachert C, Gevaert P, Van Cauwenberge P. Staphylococcus aureus superantigens and airway disease. Curr Allergy Asthma Rep 2002;2:252258.
  • 63
    Sasama J, Sherris DA, Shin SH, Kephart GM, Kern EB, Ponikau JU. New paradigm for the roles of fungi and eosinophils in chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2005;13:28.
  • 64
    Inoue Y, Matsuwaki Y, Shin SH, Ponikau JU, Kita H. Nonpathogenic, environmental fungi induce activation and degranulation of human eosinophils. J Immunol 2005;175:54395447.
  • 65
    Ponikau JU, Sherris DA, Weaver A, Kita H. Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol 2005;115:125131.
  • 66
    Pang YT, Eskici O, Wilson JA. Nasal polyposis: role of subclinical delayed food hypersensitivity. Otolaryngol Head Neck Surg 2000;122:298301.
  • 67
    Rugina M, Serrano E, Klossek JM, Crampette L, Stoll D, Bebear JP et al. Epidemiological and clinical aspects of nasal polyposis in France; the ORLI group experience. Rhinology 2002;40:7579.
  • 68
    Hellings P, Jorissen M, Ceuppens JL. The Waldeyer's ring. Acta Otorhinolaryngol Belg 2000;54:237241.
  • 69
    Haapaniemi JJ. Adenoids in school-aged children. J Laryngol Otol 1995;109:196202.
  • 70
    Huang SW, Giannoni C. The risk of adenoid hypertrophy in children with allergic rhinitis. Ann Allergy Asthma Immunol 2001;87:350355.
  • 71
    Gryczynska D, Kobos J, Zakrzewska A. Relationship between passive smoking, recurrent respiratory tract infections and otitis media in children. Int J Pediatr Otorhinolaryngol 1999;49(Suppl. 1): S275S278.
  • 72
    Vinke JG, KleinJan A, Severijnen LW, Hoeve LJ, Fokkens WJ. Differences in nasal cellular infiltrates between allergic children and age-matched controls. Eur Respir J 1999;13:797803.
  • 73
    Nguyen LH, Manoukian JJ, Sobol SE, Tewfik TL, Mazer BD, Schloss MD et al. Similar allergic inflammation in the middle ear and the upper airway: evidence linking otitis media with effusion to the united airways concept. J Allergy Clin Immunol 2004;114:11101115.
  • 74
    Papatziamos G, Van Der Ploeg I, Hemlin C, Patwardhan A, Scheynius A. Increased occurrence of IgE+ and FcepsilonRI+ cells in adenoids from atopic children. Allergy 1999;54:916925.
  • 75
    Cassano P, Gelardi M, Cassano M, Fiorella ML, Fiorella R. Adenoid tissue rhinopharyngeal obstruction grading based on fiberendoscopic findings: a novel approach to therapeutic management. Int J Pediatr Otorhinolaryngol 2003;67:13031309.
  • 76
    Cengel S, Akyol MU. The role of topical nasal steroids in the treatment of children with otitis media with effusion and/or adenoid hypertrophy. Int J Pediatr Otorhinolaryngol 2006;70:639645.
  • 77
    Demain JG, Goetz DW. Pediatric adenoidal hypertrophy and nasal airway obstruction: reduction with aqueous nasal beclomethasone. Pediatrics 1995;95:355364.
  • 78
    Criscuoli G, D'Amora S, Ripa G, Cinquegrana G, Mansi N, Impagliazzo N et al. Frequency of surgery among children who have adenotonsillar hypertrophy and improve after treatment with nasal beclomethasone. Pediatrics 2003;111:e236e238.
  • 79
    Georgalas C, Thomas K, Owens C, Abramovich S, Lack G. Medical treatment for rhinosinusitis associated with adenoidal hypertrophy in children: an evaluation of clinical response and changes on magnetic resonance imaging. Ann Otol Rhinol Laryngol 2005;114:638644.
  • 80
    Skoner DP, Doyle WJ, Chamovitz AH, Fireman P. Eustachian tube obstruction after intranasal challenge with house dust mite. Arch Otolaryngol Head Neck Surg 1986;112:840842.
  • 81
    Hardy SM, Heavner SB, White DR, McQueen CT, Prazma J, Pillsbury HC. Late-phase allergy and Eustachian tube dysfunction. Otolaryngol Head Neck Surg 2001;125:339345.
  • 82
    Pollock HW, Ebert CS, Dubin MG, White DR, Prazma J, Pillsbury HC 3rd. The role of soluble interleukin-4 receptor and interleukin-5 antibody in preventing late-phase allergy-induced Eustachian tube dysfunction. Otolaryngol Head Neck Surg 2002;127:169176.
  • 83
    Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis 1989;160:8394.
  • 84
    Wright ED, Hurst D, Miotto D, Giguere C, Hamid Q. Increased expression of major basic protein (MBP) and interleukin-5(IL-5) in middle ear biopsy specimens from atopic patients with persistent otitis media with effusion. Otolaryngol Head Neck Surg 2000;123:533538.
  • 85
    Hurst DS, Venge P. Evidence of eosinophil, neutrophil, and mast-cell mediators in the effusion of OME patients with and without atopy. Allergy 2000;55:435441.
  • 86
    Rylander R, Megevand Y. Environmental risk factors for respiratory infections. Arch Environ Health 2000;55:300303.
  • 87
    Alles R, Parikh A, Hawk L, Darby Y, Romero JN, Scadding G. The prevalence of atopic disorders in children with chronic otitis media with effusion. Pediatr Allergy Immunol 2001;12:102106.
  • 88
    Cho YS, Park SY, Lee CK, Yoo B, Moon HB. Elevated substance P levels in nasal lavage fluids from patients with chronic nonproductive cough and increased cough sensitivity to inhaled capsaicin. J Allergy Clin Immunol 2003;112:695701.
  • 89
    Gawchik S, Goldstein S, Prenner B, John A. Relief of cough and nasal symptoms associated with allergic rhinitis by mometasone furoate nasal spray. Ann Allergy Asthma Immunol 2003;90:416421.
  • 90
    Ciprandi G, Tosca M, Ricca V, Passalacqua G, Riccio AM, Bagnasco M et al. Cetirizine treatment of rhinitis in children with pollen allergy: evidence of its antiallergic activity. Clin Exp Allergy 1997;27:11601166.
  • 91
    Jackson-Menaldi CA, Dzul AI, Holland RW. Allergies and vocal fold edema: a preliminary report. J Voice 1999;13: 113122.
  • 92
    Williams AJ, Baghat MS, Stableforth DE, Cayton RM, Shenoi PM, Skinner C. Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality. Thorax 1983;38:813821.
  • 93
    DelGaudio JM. Steroid inhaler laryngitis: dysphonia caused by inhaled fluticasone therapy. Arch Otolaryngol Head Neck Surg 2002;128:677681.
  • 94
    Wang DY, Chan A, Smith JD. Management of allergic rhinitis: a common part of practice in primary care clinics. Allergy 2004;59:315319.